• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[局部晚期宫颈癌患者接受腹腔镜手术或开腹手术预后的比较分析]

[Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].

作者信息

Xu Y P, Wang Z Q, Liang X D, Wang Y, Wang J L

机构信息

Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, ChinaXu Yanping is working on the Department of Obstetrics and Gynecology, Xiamen Haicang Hospital, Xiamen 361026, China.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 2020 Sep 25;55(9):609-616. doi: 10.3760/cma.j.cn112141-20200727-00612.

DOI:10.3760/cma.j.cn112141-20200727-00612
PMID:32957749
Abstract

To compare the prognosis of patients with cervical cancer in stage Ⅰb2-Ⅱa2 undergoing laparoscopic radical hysterectomy or abdominal radical hysterectomy. From January 1, 2009 to December 31, 2018, patients with stage Ⅰb2-Ⅱa2 who underwent laparoscopic or abdominal radical hysterectomy (laparoscopic group and abdominal group) in Peking University People's Hospital were collected. The clinicopathological data were retrospectively analyzed. There were 237 cases in this study, including 115 cases in laparoscopic group and 122 cases in abdominal group. The clinicopathological characteristics, surgery-related complications, recurrence and death were analyzed between the two groups. The related factors of recurrence and death were also analyzed.During laparoscopic surgery, the pressure of the carbon dioxide pneumoperitoneum were controlled, to try avoid the tumor tissue in the vagina from being exposed to the abdominal cavity when taking out the uterine specimen through the vagina, and fully flushed the abdominal cavity with sterile water after the specimen was taken out. (1) Clinicopathological characteristics: there was no significant differences between the two groups among age, pathological type, pathological grade, clinical stage, depth of interstitial infiltration, lymph node metastasis,parametrial infiltration, vaginal stump infiltration, lymph-vascular space invasion (LVSI), neoadjuvant chemotherapy, and postoperative adjuvant treatments (all >0.05). (2) Surgery-related complications: the incidence of surgery-related complications in the laparoscopic group and the abdominal group were 32.2% (37/115) and 25.4% (31/122), respectively. There was no statistically significant difference between the two groups (>0.05). (3) Recurrence and death: during the follow-up period, the recurrence rates of the laparoscopic group and the abdominal group were respectively 15.7% (18/115) and 12.3% (15/122). There was no statistically significant difference between the two groups (=0.456). The 5-year overall survival rates of the laparoscopic group and the open group were 86.8% and 87.8%, and the 5-year tumor-free survival rates were 81.7% and 84.6%, respectively. There were no statistically significant differences between the two groups (=0.405, =0.429). (4) Analysis of related factors of recurrence and death: univariate analysis showed that neoadjuvant chemotherapy, lymph node metastasis, vaginal stump infiltration, LVSI and interstitial infiltration depth were risk factors for postoperative recurrence of cervical cancer patients (all <0.05); neoadjuvant chemotherapy, lymph node metastasis, parametrial infiltration, vaginal stump infiltration, LVSI and interstitial infiltration depth were risk factors for postoperative death in patients with cervical cancer (all <0.05). Multivariate analysis showed that neoadjuvant chemotherapy and lymph node metastasis were independent risk factors for postoperative recurrence and death of cervical cancer patients (<0.05). There is no significant difference in the prognosis of patients with cervical cancer in stage Ⅰb2-Ⅱa2 undergoing laparoscopic radical hysterectomy with non-touch operative technique and abdominal radical hysterectomy.

摘要

比较Ⅰb2-Ⅱa2期宫颈癌患者行腹腔镜根治性子宫切除术或腹式根治性子宫切除术的预后。收集2009年1月1日至2018年12月31日在北京大学人民医院行腹腔镜或腹式根治性子宫切除术的Ⅰb2-Ⅱa2期患者(腹腔镜组和腹部组)。对临床病理资料进行回顾性分析。本研究共237例,其中腹腔镜组115例,腹部组122例。分析两组患者的临床病理特征、手术相关并发症、复发及死亡情况,并分析复发和死亡的相关因素。腹腔镜手术过程中,控制二氧化碳气腹压力,经阴道取出子宫标本时尽量避免阴道内肿瘤组织暴露于腹腔,标本取出后用无菌水充分冲洗腹腔。(1)临床病理特征:两组患者在年龄、病理类型、病理分级、临床分期、间质浸润深度、淋巴结转移、宫旁浸润、阴道残端浸润、淋巴血管间隙浸润(LVSI)、新辅助化疗及术后辅助治疗等方面差异均无统计学意义(均>0.05)。(2)手术相关并发症:腹腔镜组和腹部组手术相关并发症发生率分别为32.2%(37/115)和25.4%(31/122),两组差异无统计学意义(>0.05)。(3)复发与死亡:随访期间,腹腔镜组和腹部组复发率分别为15.7%(18/115)和12.3%(15/122),两组差异无统计学意义(=0.456)。腹腔镜组和开放组5年总生存率分别为86.8%和87.8%,5年无瘤生存率分别为81.7%和84.6%,两组差异均无统计学意义(=0.405,=0.429)。(4)复发和死亡相关因素分析:单因素分析显示,新辅助化疗、淋巴结转移、阴道残端浸润、LVSI及间质浸润深度是宫颈癌患者术后复发的危险因素(均<0.05);新辅助化疗、淋巴结转移、宫旁浸润、阴道残端浸润、LVSI及间质浸润深度是宫颈癌患者术后死亡的危险因素(均<0.05)。多因素分析显示,新辅助化疗和淋巴结转移是宫颈癌患者术后复发和死亡的独立危险因素(<0.05)。Ⅰb2-Ⅱa2期宫颈癌患者行腹腔镜根治性子宫切除术采用非接触手术技术与腹式根治性子宫切除术的预后无显著差异。

相似文献

1
[Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].[局部晚期宫颈癌患者接受腹腔镜手术或开腹手术预后的比较分析]
Zhonghua Fu Chan Ke Za Zhi. 2020 Sep 25;55(9):609-616. doi: 10.3760/cma.j.cn112141-20200727-00612.
2
[Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].[I a2-II a2期宫颈癌腹腔镜与开腹根治性子宫切除术后的长期肿瘤学结局:一项配对队列研究]
Zhonghua Fu Chan Ke Za Zhi. 2015 Dec;50(12):894-901.
3
[Efficacy and safety of laparoscopic radical hysterectomy for early cervical adenocarcinoma].腹腔镜根治性子宫切除术治疗早期宫颈腺癌的疗效与安全性
Zhonghua Fu Chan Ke Za Zhi. 2020 Sep 25;55(9):600-608. doi: 10.3760/cma.j.cn112141-20200410-00313.
4
[Comparison of safety and efficacy of laparoscopic versus abdominal radical hysterectomy in the treatment of patients with stage I a2-II b cervical cancer].腹腔镜与腹式根治性子宫切除术治疗Ⅰa2 - Ⅱb期宫颈癌患者的安全性和有效性比较
Zhonghua Fu Chan Ke Za Zhi. 2015 Dec;50(12):915-22.
5
Clinical Outcomes in Early Cervical Cancer Patients Treated with Nerve Plane-sparing Laparoscopic Radical Hysterectomy.神经平面保留腹腔镜根治性子宫切除术治疗早期宫颈癌患者的临床结局。
J Minim Invasive Gynecol. 2020 Mar-Apr;27(3):687-696. doi: 10.1016/j.jmig.2019.04.025. Epub 2019 May 7.
6
[Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage Ⅰa1 (LVSI)-Ⅰb1 cervical cancer patients with different tumor size: a big database in China].[不同肿瘤大小的Ⅰa1期(淋巴血管间隙浸润)-Ⅰb1期宫颈癌患者腹腔镜手术与开腹手术的长期肿瘤学结局:一项中国大型数据库研究]
Zhonghua Fu Chan Ke Za Zhi. 2020 Sep 25;55(9):589-599. doi: 10.3760/cma.j.cn112141-20200515-00411.
7
[Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].Ⅰb2期和Ⅱa2期宫颈鳞状细胞癌患者根治性手术的结局与预后
Zhonghua Fu Chan Ke Za Zhi. 2022 May 25;57(5):361-369. doi: 10.3760/cma.j.cn112141-20220326-00194.
8
[Comparison of the short-term and long-term outcomes of laparoscopic surgery and open surgery for early-stage cervical cancer].[早期宫颈癌腹腔镜手术与开放手术的短期和长期结果比较]
Zhonghua Zhong Liu Za Zhi. 2017 Jun 23;39(6):458-466. doi: 10.3760/cma.j.issn.0253-3766.2017.06.011.
9
[Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].[新辅助化疗联合根治性子宫切除术治疗无高危因素的Ⅰb2期和Ⅱa2期宫颈鳞癌的预后分析]
Zhonghua Fu Chan Ke Za Zhi. 2018 Apr 25;53(4):248-256. doi: 10.3760/cma.j.issn.0529-567x.2018.04.008.
10
[Comparison of the clinical efficacy of different treatments based on radical surgery in stage Ⅰ b2 and Ⅱa2 cervical cancer: a prospective randomized control study].[基于根治性手术的不同治疗方案对Ⅰb2期和Ⅱa2期宫颈癌的临床疗效比较:一项前瞻性随机对照研究]
Zhonghua Fu Chan Ke Za Zhi. 2016 Jul 25;51(7):524-9. doi: 10.3760/cma.j.issn.0529-567X.2016.07.008.

引用本文的文献

1
TGFA expression is associated with poor prognosis and promotes the development of cervical cancer.TGFA 表达与不良预后相关,并促进宫颈癌的发展。
J Cell Mol Med. 2024 Feb;28(3):e18086. doi: 10.1111/jcmm.18086. Epub 2023 Dec 28.
2
Risk factors for additional postoperative adjuvant therapy in patients with locally advanced cervical cancer and construction of a risk model.局部晚期宫颈癌患者术后辅助治疗的危险因素及风险模型的构建
Am J Transl Res. 2022 Dec 15;14(12):8959-8968. eCollection 2022.
3
ISG15 is associated with cervical cancer development.
ISG15与宫颈癌的发展有关。
Oncol Lett. 2022 Sep 12;24(4):380. doi: 10.3892/ol.2022.13500. eCollection 2022 Oct.